Introgene B.V.
Records under this name other than patents Introgene B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,236,293 | Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer Formerly held Term ended Term ended Mar 23, 2022 · From the USPTO record | Term ended | Term ended Mar 23, 2022 | From the USPTO record |
| US 7,491,532 | Recombinant protein production in a human cell Formerly held Term ended Term ended Nov 22, 2021 · From the USPTO record | Term ended | Term ended Nov 22, 2021 | From the USPTO record |
| US 7,132,280 | Recombinant protein production in a human cell Formerly held Term ended Term ended Feb 5, 2021 · From the USPTO record | Term ended | Term ended Feb 5, 2021 | From the USPTO record |
| US 7,470,523 | Recombinant protein production in a human cell Formerly held Term ended Term ended Jun 9, 2020 · From the USPTO record | Term ended | Term ended Jun 9, 2020 | From the USPTO record |
| US 6,913,922 | Serotype of adenovirus and uses thereof Formerly held Term ended Term ended May 18, 2020 · From the USPTO record | Term ended | Term ended May 18, 2020 | From the USPTO record |
| US 6,855,544 | Recombinant protein production in a human cell Formerly held Term ended Term ended Apr 14, 2020 · From the USPTO record | Term ended | Term ended Apr 14, 2020 | From the USPTO record |
| US 6,869,936 | Means and methods for fibroblast-like or macrophage-like cell transduction Formerly held Term ended Term ended Mar 3, 2020 · From the USPTO record | Term ended | Term ended Mar 3, 2020 | From the USPTO record |
| US 6,500,919 | Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma Formerly held Term ended Term ended Dec 31, 2019 · From the USPTO record | Term ended | Term ended Dec 31, 2019 | From the USPTO record |
| US 6,447,768 | Methods of gene therapy with a DNA sequence encoding NOS Formerly held Term ended Term ended Dec 29, 2019 · From the USPTO record | Term ended | Term ended Dec 29, 2019 | From the USPTO record |
| US 7,192,759 | Production of vaccines Formerly held Term ended Term ended Nov 26, 2019 · From the USPTO record | Term ended | Term ended Nov 26, 2019 | From the USPTO record |